XGN
ExagenยทNASDAQ
--
--(--)
--
--(--)
XGN Profile
Exagen Inc.
A leading provider of autoimmune testing solutions
Healthcare Providers and Services
--
09/19/2019
NASDAQ Stock Exchange
203
12-31
Common stock
1261 Liberty Way, Suite C, Vista, California 92081
--
Exagen Inc., was founded in 2002. Exagen is committed to transforming the continuum of care for patients with debilitating and chronic autoimmune diseases through timely differential diagnosis and optimized therapeutic interventions. The company's goal is to enable rheumatologists to improve patient care through differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune related diseases, including SLE and rheumatoid arthritis or RA.
